Skip to main content
Top
Published in: European Journal of Epidemiology 11/2008

01-11-2008 | Cardiovascular Disease

Cardiovascular risk factors and mortality in patients with coronary heart disease

Authors: Christof Prugger, Jürgen Wellmann, Jan Heidrich, Stefan-Martin Brand-Herrmann, Ulrich Keil

Published in: European Journal of Epidemiology | Issue 11/2008

Login to get access

Abstract

A priority in preventive cardiology is to reduce the number of recurrent events and to prolong survival in patients with established coronary heart disease (CHD). Aim of the present study was to examine risk factors for long-term mortality in CHD patients who entered routine secondary prevention after a coronary event or intervention. Such patients, from the EUROASPIRE (EUROpean Action on Secondary Prevention through Intervention to Reduce Events) I and II studies in the region of Münster, Germany, were followed over a mean period of 8.0 years up to the end of 2005. Patients were up to 70 years of age at baseline when they were interviewed and examined using standardised methods. Baseline examination was carried out at least 6 months and at a mean of 19.5 months after the coronary event or procedure. In 367 patients from EUROASPIRE I and 380 patients from EUROASPIRE II, a total of 125 deaths (16.7%) occurred during follow-up. Multivariate analyses, using Cox proportional hazards models, established diabetes mellitus and smoking as predictors for all-cause mortality with estimated hazard rate ratios (HRRs) of 2.24 (95% confidence interval (CI): 1.43–3.49) and 1.95 (95% CI: 1.23–3.10), respectively. Significant associations were found between diabetes mellitus and cardiovascular (HRR 2.36; 95% CI: 1.31–4.24) as well as CHD mortality (HRR 2.40; 95% CI: 1.25–4.59). Systolic blood pressure was significantly associated with increased cerebrovascular disease mortality (HRR 1.04; 95% CI: 1.01 and 1.08 for 1 mmHg increase). In conclusion, long-term mortality in coronary patients from routine secondary prevention is substantial. Diabetes mellitus and smoking represent key issues in patients with established CHD.
Literature
2.
go back to reference World Health Organisation. World Health Report 2004. Geneva: World Health Organisation; 2004. World Health Organisation. World Health Report 2004. Geneva: World Health Organisation; 2004.
3.
go back to reference European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Fourth Joint European Societies’ Task Force on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil. 2007;14:S1–113. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Fourth Joint European Societies’ Task Force on Cardiovascular Disease Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil. 2007;14:S1–113.
4.
go back to reference Chambless L, Keil U, Dobson A, et al. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985–1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease. Circulation. 1997;96:3849–59.PubMed Chambless L, Keil U, Dobson A, et al. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985–1990. Multinational MONItoring of Trends and Determinants in CArdiovascular Disease. Circulation. 1997;96:3849–59.PubMed
5.
go back to reference Marschner IC, Colquhoun D, Simes RJ, et al. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators. J Am Coll Cardiol. 2001;38:56–63. doi:10.1016/S0735-1097(01)01360-2.PubMedCrossRef Marschner IC, Colquhoun D, Simes RJ, et al. Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators. J Am Coll Cardiol. 2001;38:56–63. doi:10.​1016/​S0735-1097(01)01360-2.PubMedCrossRef
6.
go back to reference Wilhelmsen L, Pyorala K, Wedel H, et al. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment. Eur Heart J. 2001;22:1119–27. doi:10.1053/euhj.2000.2481.PubMedCrossRef Wilhelmsen L, Pyorala K, Wedel H, et al. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment. Eur Heart J. 2001;22:1119–27. doi:10.​1053/​euhj.​2000.​2481.PubMedCrossRef
7.
go back to reference EUROASPIRE Study Group. EUROASPIRE: European action on secondary prevention through intervention to reduce events. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J. 1997;18:1569–82. EUROASPIRE Study Group. EUROASPIRE: European action on secondary prevention through intervention to reduce events. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. Eur Heart J. 1997;18:1569–82.
8.
go back to reference EUROASPIRE Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001;22:554–72. doi:10.1053/euhj.2001.2610. EUROASPIRE Study Group. Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries; principal results from EUROASPIRE II Euro Heart Survey Programme. Eur Heart J. 2001;22:554–72. doi:10.​1053/​euhj.​2001.​2610.
10.
go back to reference Leander K, Wiman B, Hallqvist J, et al. Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology Program (SHEEP). Eur J Cardiovasc Prev Rehabil. 2007;14:532–7. doi:10.1097/HJR.0b013e328012e3cc.PubMedCrossRef Leander K, Wiman B, Hallqvist J, et al. Primary risk factors influence risk of recurrent myocardial infarction/death from coronary heart disease: results from the Stockholm Heart Epidemiology Program (SHEEP). Eur J Cardiovasc Prev Rehabil. 2007;14:532–7. doi:10.​1097/​HJR.​0b013e328012e3cc​.PubMedCrossRef
13.
go back to reference Wong ND, Cupples LA, Ostfeld AM, et al. Risk factors for long-term coronary prognosis after initial myocardial infarction: the Framingham Study. Am J Epidemiol. 1989;130:469–80.PubMed Wong ND, Cupples LA, Ostfeld AM, et al. Risk factors for long-term coronary prognosis after initial myocardial infarction: the Framingham Study. Am J Epidemiol. 1989;130:469–80.PubMed
14.
15.
go back to reference Heidrich J, Liese AD, Kalic M, et al. Secondary prevention of coronary heart disease Results from EUROASPIRE I and II in the region of Münster, Germany. Dtsch Med Wochenschr. 2002;127:667–72. doi:10.1055/s-2002-23480.PubMedCrossRef Heidrich J, Liese AD, Kalic M, et al. Secondary prevention of coronary heart disease Results from EUROASPIRE I and II in the region of Münster, Germany. Dtsch Med Wochenschr. 2002;127:667–72. doi:10.​1055/​s-2002-23480.PubMedCrossRef
16.
go back to reference EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet. 2001;357:995–1001. doi:10.1016/S0140-6736(00)04235-5. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. Lancet. 2001;357:995–1001. doi:10.​1016/​S0140-6736(00)04235-5.
18.
go back to reference Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706. doi:10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O.PubMedCrossRef Gooley TA, Leisenring W, Crowley J, et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706. doi:10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O.PubMedCrossRef
19.
go back to reference Hosmer DW, Lemeshow S. Applied survival analysis. Regression modeling of time to event data. New York: John Wiley & Sons; 1999. Hosmer DW, Lemeshow S. Applied survival analysis. Regression modeling of time to event data. New York: John Wiley & Sons; 1999.
20.
go back to reference MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765–74. doi:10.1016/0140-6736(90)90878-9.PubMedCrossRef MacMahon S, Peto R, Cutler J, et al. Blood pressure, stroke, and coronary heart disease Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet. 1990;335:765–74. doi:10.​1016/​0140-6736(90)90878-9.PubMedCrossRef
21.
go back to reference Boshuizen HC, Lanti M, Menotti A, et al. Effects of past and recent blood pressure and cholesterol level on coronary heart disease and stroke mortality, accounting for measurement error. Am J Epidemiol. 2007;165:398–409. doi:10.1093/aje/kwk021.PubMedCrossRef Boshuizen HC, Lanti M, Menotti A, et al. Effects of past and recent blood pressure and cholesterol level on coronary heart disease and stroke mortality, accounting for measurement error. Am J Epidemiol. 2007;165:398–409. doi:10.​1093/​aje/​kwk021.PubMedCrossRef
22.
go back to reference Husten CG, Shelton DM, Chrismon JH, et al. Cigarette smoking and smoking cessation among older adults: United States, 1964–94. Tob Control. 1997;6:175–80.PubMedCrossRef Husten CG, Shelton DM, Chrismon JH, et al. Cigarette smoking and smoking cessation among older adults: United States, 1964–94. Tob Control. 1997;6:175–80.PubMedCrossRef
23.
go back to reference Junge B, Nagel M. Smoking behavior in Germany. Gesundheitswesen. 1999;61:S121–5.PubMed Junge B, Nagel M. Smoking behavior in Germany. Gesundheitswesen. 1999;61:S121–5.PubMed
Metadata
Title
Cardiovascular risk factors and mortality in patients with coronary heart disease
Authors
Christof Prugger
Jürgen Wellmann
Jan Heidrich
Stefan-Martin Brand-Herrmann
Ulrich Keil
Publication date
01-11-2008
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 11/2008
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-008-9291-x

Other articles of this Issue 11/2008

European Journal of Epidemiology 11/2008 Go to the issue